Top Machine Learning Companies (2,765)

Market Expansion: Geographic reach is widening quickly, with operations scaling across many U.S. states and stated plans to enter the U.K. and Ireland alongside continued growth in New Zealand and Australia. Customer adoption also broadened materially, with notable increases in the number of ranches and farms using the platform.

Investor Backing & Capital Strength: Capital access strengthened through sizable late‑stage rounds at markedly higher valuations within a short span, with independent confirmations of the most recent raise. This trajectory indicates strong investor confidence to fund continued commercial and product expansion.

Strong Revenue Growth: New Zealand filings and reporting indicate materially higher subscription and segment revenues over recent periods. These financial signals align with increased collar deployments and a larger installed base.

Product Line Growth: The product footprint is expanding, with S&P highlighting Kensho Link and the LLM‑ready API while Kensho adds datasets like private‑company financials and Capital IQ Estimates plus integrations with Anthropic, ChatGPT, Amazon Quick Suite, and Databricks. This indicates broader functionality and distribution across enterprise AI workflows.

Strategic Partnerships: Enterprise collaborations are scaling, exemplified by RBC Capital Markets integrating Kensho/S&P Global data to 8,000 employees and reported ties into ecosystems such as Cohere and MCP-enabled chat interfaces. These relationships suggest growing commercial reach through key institutional channels.

Future-Ready Strategy: S&P Global’s July 2026 reorganization established Kensho Data & Platforms as the client-facing data-product and AI-delivery layer, positioning the business to accelerate AI-powered products. This structural elevation signals commitment to AI-led growth across S&P’s portfolio.

Strong Revenue Growth: Recent quarters show record revenue with both net interest income and fee income increasing. Capital-markets and advisory income also strengthened, contributing to broad-based top-line momentum.

Profitability: Net income has risen materially year over year alongside positive operating leverage. Management commentary highlights higher earnings power, reflected in stronger quarterly results and upgraded outlook items.

Market Expansion: The acquisition of FirstBank expanded the franchise in Colorado and Arizona and added loans, deposits, and assets. Plans to open more than 300 new branches by 2030 and related hiring signal an active push into new and existing markets.

Strong Revenue Growth: Revenue is portrayed as rising over recent years, with directional estimates indicating 2023–24 gains and Polish filings showing long‑term expansion, albeit not strictly linear. This points to continued top‑line momentum even as exact consolidated figures remain private.

Market Expansion: Operations are described across 90+ markets with 4,000+ campaigns and ongoing hiring in multiple regions, and the company states its global expansion is still gathering pace. Geographic references include teams and roles spanning the U.S., Korea, Romania, Poland and other markets.

Product Line Growth: A self‑service platform (rtb.com) launched in 2026 targets SMBs and agencies, expanding beyond the traditional enterprise focus. Offerings are also characterized as extending into DSP, CTV/OTT, first‑party advertising, and AI/Deep Learning.

Diversified Revenue Streams: Cox is expanding beyond its traditional broadband, automotive, and media businesses into cleantech, public‑sector software, digital media, greenhouse agriculture, and a new Cox Outdoors segment. Recent activity includes acquisitions like Fullpath and the substantial build‑out of Cox Farms, indicating multiple growth pillars.

Innovation-Driven Growth: Cumulative cleantech and sustainability investments have surpassed $3 billion, and the company has launched programs and deals aimed at scaling next‑generation platforms. Moves such as acquiring an AI/data‑marketing platform and developing advanced greenhouse agriculture signal an innovation‑led expansion path.

Investor Backing & Capital Strength: A major combination of communications assets with Charter delivered billions in cash and preferred/common equity, while commentary describes a robust balance sheet and substantial liquidity. This financial flexibility supports continued capital deployment across new and emerging businesses.

Investor Backing & Capital Strength: Significant financing includes a $56.1M Series C in 2024 and additional growth-capital funding from CIBC Innovation Banking in March 2026, signaling continued investor confidence and runway. Company communications indicate these funds are directed toward product development, R&D, customer success, and sales.

Product Line Growth: Recent launches and expansions span Renewal Analytics, workers’ compensation capabilities (including a claims-triage solution), and a major expansion of the Group Health analytics platform, alongside an integrated Risk Management Life Cycle solution. This pattern points to broadening coverage across underwriting, renewals, and claims.

Customer Loyalty & Retention: Current materials highlight hundreds of enterprise deployments with very high client retention, paired with ongoing wins and deployments in 2025–26 (e.g., Community Health Options, Evolution Risk Partners, and continued 2026 additions). These signals suggest a sticky and expanding customer base.

Strong Revenue Growth: Consistent year-over-year gains are highlighted, including 12 consecutive quarters as of late 2025. Growth was linked to adding 200+ net-new brands and increased engagement with curation offerings such as OpenXSelect.

Market Expansion: Geographic reach broadened with TV by OpenX entering seven additional international markets in 2024 and a new Mexico office launching LATAM expansion in 2025. Additional investment in publisher-development personnel in January 2026 is described as supporting the next phase of publisher growth.

Innovation-Driven Growth: New offerings like OpenXSelect and AI/ML capabilities via OpenX IQ, alongside advances in CTV, are positioned as commercial drivers. A post-launch uplift in monetized impressions for TV by OpenX and ongoing product rollouts signal traction.

Strong Revenue Growth: External growth rankings and rising federal obligations alongside continued 2026 awards indicate rapid multi‑year expansion. Company statements and third‑party profiles also point to ongoing momentum rather than a one‑off spike.

Diversified Customer Base: Work spans multiple U.S. defense organizations and NATO, including Navy, Marine Corps, Air Force, Space Force, and DARPA. Access to vehicles such as OASIS+, SeaPort NxG, EWAAC, and SBIR Phase III widens routes to varied government buyers.

Strong Hiring & Retention: Active postings for senior engineering and cybersecurity roles, multi‑site hiring (e.g., Colorado and Hawaii), and facility expansion signal ongoing team scale‑up. State‑backed job‑creation plans and documented staff increases reinforce organizational growth capacity.

Strong Revenue Growth: ARR is reported to have surpassed $200M by June 2026 after crossing $100M in early 2025, with five consecutive years of 100% year-over-year growth. This consistent doubling signals rapid scaling at substantial revenue levels.

Investor Backing & Capital Strength: Funding rounds include $75M in 2024 at a valuation above $1B and a $250M Series E in 2025 at a reported $2.2B, with total capital raised cited at $400M+. Such late-stage financing and rising valuations indicate robust access to growth capital.

Strong Market Position & Advantage: Adoption is described as reaching roughly 1 in 6 U.S. apartments, with deep penetration among large property managers and hundreds of operators. Expansion into healthcare and notable distribution relationships have broadened its commercial footprint.

Strong Revenue Growth: Revenue has scaled materially, with ARR approaching the $400M mark and leadership targeting expansion toward $1B, alongside earlier signals such as 42% YoY ARR growth and very high renewal/net expansion. Feedback suggests recent indications of ~$300–350M revenue and expanding customer/end‑user coverage reinforce continued momentum.

Investor Backing & Capital Strength: A majority investment by Vista Equity Partners at an approximately $3B valuation signals strong capital support and confidence in the company’s scaling prospects. Feedback suggests this backing, including associated financing, enables continued product and geographic expansion.

Strong Market Position & Advantage: Repeated recognition as a Leader in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s EUEM Wave points to sustained category leadership. Large‑scale enterprise adoption (e.g., 1,500+ customers and 25M+ employees served) further entrenches competitive positioning.

Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.

Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.

Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.

Strong Revenue Growth: ARR moved from surpassing $300M in June 2025 to exceeding $400M by May 2026, indicating a substantial year-over-year increase. The company also reported a 36% five-year organic CAGR in 2024, underscoring sustained momentum.

Product Line Growth: Edwin AI recurring revenue is reported to be growing around 200% year over year and contributing about one-third of total bookings. The December 2025 Catchpoint acquisition expanded capabilities into internet performance and digital experience monitoring.

Market Expansion: Larger enterprise accounts grew more than 25% year over year in 2025 and the company cited 700+ enterprise customers by late 2025. More than 30% of new customers came from outside the U.S., indicating ongoing international expansion.

Product Line Growth: Growth across non‑COVID medicines such as Eliquis, Padcev, the Vyndaqel family, Lorbrena, Nurtec/Vydura and oncology biosimilars has been robust. Launched and acquired products are showing sustained double‑digit operational gains, adding meaningful momentum.

Resilient & Sustainable Growth: Excluding COVID products, the underlying portfolio delivered mid‑single‑digit operational growth in 2025 and continued at a similar pace in early 2026, more than offsetting part of the COVID‑related decline. Reported revenue also returned to modest year‑over‑year growth in the first half of 2026, indicating stabilization.

Future-Ready Strategy: Management raised the midpoint of 2026 revenue guidance and continues to invest heavily in a broad late‑stage pipeline. This posture signals confidence that newer launches and acquired assets can drive the next leg of growth.

Investor Backing & Capital Strength: Investors have continued to back the company with significant new capital post‑spinout, including additional rounds that independent sources corroborate. This suggests a solid financial runway to support ongoing expansion.

Innovation-Driven Growth: The company has shifted firmly toward an AI‑native customer‑experience platform, highlighting sustained investment in agentic architecture and frequent AI product releases. This pattern indicates active product expansion rather than a stagnant portfolio.

Customer Loyalty & Retention: The customer base includes recognizable brands and examples of multi‑year usage, alongside reports of improved retention and faster renewals. These signals point to durable relationships and expanding adoption among existing accounts.

Strong Revenue Growth: Recent results indicate total revenue increased year over year in 2025 and continued to rise in the latest reported quarter. Guidance and quarterly updates point to ongoing top-line expansion even as mix shifts occur.

Resilient & Sustainable Growth: Underlying annual contract value expanded and accelerated in 2026, with management indicating continued growth despite the transition to hosted licensing. This suggests the core subscription base is strengthening even when reported revenue timing varies.

Diversified Revenue Streams: Growth is visible in both the software business and the milestone-driven drug discovery segment. The latter stepped up meaningfully in recent periods, complementing steady software momentum.

Strong Revenue Growth: Subscription revenue is described as growing at a double‑digit year‑over‑year pace as of late 2023, signaling solid momentum in the core recurring model.

Customer Loyalty & Retention: Renewal rates are reported as extremely high, indicating sticky relationships and a durable subscription base.

Market Expansion: The underlying hotel‑data network has expanded materially to a larger global sample across nearly 200 countries, pointing to broader reach and scale.

Investor Backing & Capital Strength: Strategic capital is substantial, with $1B raised in 2025 to fund expansion into an AI productivity platform. This provides significant financial capacity for acquisitions and product development.

Product Line Growth: The company has broadened its footprint through acquisitions including Coda (now part of the suite), GPTZero, Rows, and Fathom, while integrating advanced AI capabilities like Superhuman Go and agent ecosystems. These moves expand the offering well beyond the original email client.

Market Expansion: Current materials cite 40M+ daily active users and 50K+ organizations, reflecting the larger Superhuman/Grammarly platform after the rebrand. Continued M&A in 2026 further extends reach into authenticity and meeting-productivity use cases.

Strong Revenue Growth: Available disclosures indicate revenue grew at a triple‑digit rate year over year in early 2026 and was later described as roughly $200M after multiple years of doubling. These signals point to rapid scaling beyond a purely funding‑led story.

Investor Backing & Capital Strength: Back‑to‑back late‑stage rounds in 2026, including a nine‑figure Series D followed quickly by a nine‑figure Series E with a stepped‑up valuation, suggest deep capital access and investor conviction. The rapid valuation increase provides additional financial flexibility for expansion.

Strategic Partnerships: Announcements in 2026 with organizations such as Atlantic Health and Priority Health indicate expanding distribution channels beyond direct employer sales. These relationships broaden market reach and embed the offering within health systems and plans.

Product Line Growth: The platform has expanded from data reduction/privacy into Large Tabular Models and Myelin for stateful AI agents, signaling a broader offering. Company materials describe substantial production usage and named deployments, indicating movement beyond a single-product footprint.

Strategic Partnerships: The company joined the Google Cloud Partner Advantage program and lists availability/integrations across major ecosystems, including cloud marketplaces and a recorded Databricks partnership. These channels suggest deeper enterprise distribution with managed, hybrid, and self-managed deployment options.

Investor Backing & Capital Strength: A $45M Series A led by top-tier investors is documented, and the company now states it has raised more than $60M. This points to continued access to capital even though the most clearly documented major round remains the 2023 Series A.

Strong Revenue Growth: Accuris reported it “substantially accelerated revenue growth” in 2024 and was on track to exceed its financial targets. It also described “exceptional momentum” in Q1 2025.

Product Line Growth: The company expanded its portfolio with Accuris Thread in 2025 and, in 2026, launched AI Assistant, BOM Intelligence, Change Impact Analysis, and a broader Engineering Intelligence platform. These moves indicate continued investment and expansion.

Market Expansion: Operational scale grew with a new Denver headquarters and offices in the UK, India, Malaysia, and Japan, alongside global headcount reaching 1,000+ across 20 countries. Accuris also reports 6,500+ organizations and 900,000 users, up from earlier disclosures.